Bibliografía del artículo
Bibliografía
1. Larrey D. Drug-induced liver diseases. J Hepatol 32:77-88, 2000.
2. The UK Hemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with hemochromatosis. Gut 41:841-844, 1997.
3. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 130:953-962, 1999.
4. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 11:272-276, 1990.
5. Farrell GC. Drug-induced liver disease. London: Churchill Livingstone; 1994.
6. Larrey D, Pageaux GP. Genetic predisposition to drug-induced hepatotoxicity. J Hepatol 26:12-21, 197.
7. Berson A, Fréneaux E, Larrey D, et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 20:336-342, 1994.
8. Wysowski DK, Freiman JP, Tourtelot JB, Horton ML. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 118:860-864, 1993.
9. Hagley MT, Hulisz DT, Burus CM. Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann Pharmacother 27:228-231, 1993.
10. Victorio RM, Silveira JC, Baptista A, de Moura MC. Jaundice associated with naproxen. Postgrad Med J 56:368-370, 1980.
11. Zafrani ES, Ishak KG, Rudzki C. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Dig Dis Sci 24:385-396, 1979.
12. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 7:230-236, 1987.
13. Veneri RJ, Gordon SC. Anabolic steroid-induced cholestasis: choleretic response to corticosteroids. J Clin Gastroenterol 10:467-468, 1988.
14. Artímez ML, Fernández E, Rodríguez M, González M, Rodrigo L. Hepatitis tóxica por ticlopidina. Tres nuevos casos. Rev Esp Enf Digest 89:796-797, 1997.
15. Díaz Fuenzalida A, Valdés Socín H, Lauddano O, Avagnina A, Findor JA. Colestasis asociada a ticlopidina. Gastroenterol Hepatol 20:128-130, 1997.
16. Larrey D, Vial T, Micaleff A, et al. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 33:368-371, 1992.
17. Ropero-Gradilla P, González-Fernández FA, Briceño-Polacre O, Villegas-Martínez A. Distribución geográfica de las mutaciones del gen HFE en España. Med Clin (Barc) 125:794-795, 2005.
18. Ropero P, Briceño O, Mateo M, Polo M, Mora A, González FA, Villegas A. Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in a cohort of 1000 neonates in Madrid (Spain). Ann Hematol 85:323-326, 2006.
19. Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 32:48-62, 2000.
20. Andrews NC. Disorders of iron metabolism. N Engl J Med 341:1986-1995, 1999.
21. Conrad ME, Umbreit JN, Moore EG. Iron absorption and transport. Am J Med Sci 318:213-219, 1999.
22. Andrews NC. The iron transporter DMT1. Int J Biochem Cell Biol 31:991-994, 1999.